{"title":"革命性的癌症治疗:导航细胞信号网络的复杂景观。","authors":"Hao Zhang","doi":"10.17219/acem/205024","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer progression and therapeutic resistance are propelled by the remarkable plasticity of signaling networks, which dynamically rewire under selective pressures to maintain proliferation, enable immune evasion and promote metastasis. Despite advances in precision oncology, the dynamic crosstalk between tumor cells, non-coding genomes and the microenvironment continues to undermine treatment efficacy. This call for submissions, Revolutionizing Cancer Treatment: Navigating the Intricate Landscape of Cellular Signaling Networks, seeks cutting-edge research that dissects these adaptive mechanisms through innovative technologies - from single-cell multi-omics and spatial transcriptomics to AI-powered network modeling. We welcome studies leveraging physiomimetic models (e.g., organoids, 3D-bioprinted ecosystems) to decode tumor heterogeneity, as well as translational work targeting emergent vulnerabilities at the intersection of epigenetics, metabolic reprogramming and stromal interactions. By integrating systems biology with computational and experimental approaches, this collection aims to catalyze the design of adaptive therapies that outmaneuver cancer's evolutionary resilience.</p>","PeriodicalId":7306,"journal":{"name":"Advances in Clinical and Experimental Medicine","volume":" ","pages":"669-671"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Revolutionizing cancer treatment: Navigating the intricate landscape of cellular signaling networks.\",\"authors\":\"Hao Zhang\",\"doi\":\"10.17219/acem/205024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cancer progression and therapeutic resistance are propelled by the remarkable plasticity of signaling networks, which dynamically rewire under selective pressures to maintain proliferation, enable immune evasion and promote metastasis. Despite advances in precision oncology, the dynamic crosstalk between tumor cells, non-coding genomes and the microenvironment continues to undermine treatment efficacy. This call for submissions, Revolutionizing Cancer Treatment: Navigating the Intricate Landscape of Cellular Signaling Networks, seeks cutting-edge research that dissects these adaptive mechanisms through innovative technologies - from single-cell multi-omics and spatial transcriptomics to AI-powered network modeling. We welcome studies leveraging physiomimetic models (e.g., organoids, 3D-bioprinted ecosystems) to decode tumor heterogeneity, as well as translational work targeting emergent vulnerabilities at the intersection of epigenetics, metabolic reprogramming and stromal interactions. By integrating systems biology with computational and experimental approaches, this collection aims to catalyze the design of adaptive therapies that outmaneuver cancer's evolutionary resilience.</p>\",\"PeriodicalId\":7306,\"journal\":{\"name\":\"Advances in Clinical and Experimental Medicine\",\"volume\":\" \",\"pages\":\"669-671\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Clinical and Experimental Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17219/acem/205024\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17219/acem/205024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Revolutionizing cancer treatment: Navigating the intricate landscape of cellular signaling networks.
Cancer progression and therapeutic resistance are propelled by the remarkable plasticity of signaling networks, which dynamically rewire under selective pressures to maintain proliferation, enable immune evasion and promote metastasis. Despite advances in precision oncology, the dynamic crosstalk between tumor cells, non-coding genomes and the microenvironment continues to undermine treatment efficacy. This call for submissions, Revolutionizing Cancer Treatment: Navigating the Intricate Landscape of Cellular Signaling Networks, seeks cutting-edge research that dissects these adaptive mechanisms through innovative technologies - from single-cell multi-omics and spatial transcriptomics to AI-powered network modeling. We welcome studies leveraging physiomimetic models (e.g., organoids, 3D-bioprinted ecosystems) to decode tumor heterogeneity, as well as translational work targeting emergent vulnerabilities at the intersection of epigenetics, metabolic reprogramming and stromal interactions. By integrating systems biology with computational and experimental approaches, this collection aims to catalyze the design of adaptive therapies that outmaneuver cancer's evolutionary resilience.
期刊介绍:
Advances in Clinical and Experimental Medicine has been published by the Wroclaw Medical University since 1992. Establishing the medical journal was the idea of Prof. Bogumił Halawa, Chair of the Department of Cardiology, and was fully supported by the Rector of Wroclaw Medical University, Prof. Zbigniew Knapik. Prof. Halawa was also the first editor-in-chief, between 1992-1997. The journal, then entitled "Postępy Medycyny Klinicznej i Doświadczalnej", appeared quarterly.
Prof. Leszek Paradowski was editor-in-chief from 1997-1999. In 1998 he initiated alterations in the profile and cover design of the journal which were accepted by the Editorial Board. The title was changed to Advances in Clinical and Experimental Medicine. Articles in English were welcomed. A number of outstanding representatives of medical science from Poland and abroad were invited to participate in the newly established International Editorial Staff.
Prof. Antonina Harłozińska-Szmyrka was editor-in-chief in years 2000-2005, in years 2006-2007 once again prof. Leszek Paradowski and prof. Maria Podolak-Dawidziak was editor-in-chief in years 2008-2016. Since 2017 the editor-in chief is prof. Maciej Bagłaj.
Since July 2005, original papers have been published only in English. Case reports are no longer accepted. The manuscripts are reviewed by two independent reviewers and a statistical reviewer, and English texts are proofread by a native speaker.
The journal has been indexed in several databases: Scopus, Ulrich’sTM International Periodicals Directory, Index Copernicus and since 2007 in Thomson Reuters databases: Science Citation Index Expanded i Journal Citation Reports/Science Edition.
In 2010 the journal obtained Impact Factor which is now 1.179 pts. Articles published in the journal are worth 15 points among Polish journals according to the Polish Committee for Scientific Research and 169.43 points according to the Index Copernicus.
Since November 7, 2012, Advances in Clinical and Experimental Medicine has been indexed and included in National Library of Medicine’s MEDLINE database. English abstracts printed in the journal are included and searchable using PubMed http://www.ncbi.nlm.nih.gov/pubmed.